SIRION Biotech Expands US Presence in Massachusetts
Europe’s Leading Commercial Provider of Viral Vector Technology Opens Local Office in Cambridge
CAMBRIDGE, Mass.--(BUSINESS WIRE)--SIRION Biotech International Inc., a wholly-owned subsidiary of SIRION Biotech GmbH in Germany (“SIRION”), offering the most comprehensive portfolio of custom viral vectors for preclinical and clinical studies, today announced the grand opening of a new office...
Learn More
